Molecular and Cellular Advances on Drug Discovery, Pharmacology and Toxicology, 2nd Edition
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 1065
Special Issue Editors
2. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
3. Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal
Interests: molecular motors; intracellular transport; cell biology; molecular biology; neurodegeneration; drugs of abuse; pharmacology; toxicology; neurotoxicology; forensic sciences
Special Issues, Collections and Topics in MDPI journals
2. UCIBIO—Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
Interests: toxicology; pharmacology; ADME/toxicokinetics; membrane transporters; P-glycoprotein; neurodegeneration; drugs of abuse; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In biomedical sciences, the identification/discovery of novel therapeutics, efficient pharmacological interventions, and comprehensive toxicological assessments has become dominant. In recent years, there has been an unprecedented convergence of multidisciplinary research, integrating molecular and cellular biology with drug discovery, pharmacology, and toxicology. This synergy has not only accelerated the identification of potential new therapeutic targets but has also enhanced our understanding of the intricate mechanisms governing drug response and toxicity.
In an era where precision medicine, targeted therapies, and emergent drug abuse dominate scientific research, the convergence of molecular and cellular insights with drug discovery and toxicology has become indispensable, fostering a deeper understanding of the molecular foundations of diseases, the pharmacological intricacies of therapeutic agents, and the safety considerations vital for clinical translation.
In this Special Issue, we are interested in reviews and original articles describing cellular and molecular advances on drug discovery, pharmacology, and toxicology, in in vitro and in vivo models; or reporting evidence and expectations attained from the in silico modeling of existing and novel compounds with potential biological activity.
Dr. Daniel José Barbosa
Dr. Renata Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug discovery
- pharmacological activity
- toxicological profile
- in vitro models
- in vivo models
- new biological compounds
- drugs of abuse
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
